Mutations in the NHEJ Component XRCC4 Cause Primordial Dwarfism

被引:62
|
作者
Murray, Jennie E. [1 ]
van der Burg, Mirjam [2 ]
IJspeert, Hanna [2 ]
Carroll, Paula [1 ]
Wu, Qian [3 ]
Ochi, Takashi [3 ]
Leitch, Andrea [1 ]
Miller, Edward S. [4 ]
Kysela, Boris [5 ]
Jawad, Alireza [2 ]
Bottani, Armand [6 ]
Brancati, Francesco [7 ]
Cappa, Marco [8 ]
Cormier-Daire, Valerie [9 ]
Deshpande, Charu [10 ]
Faqeih, Eissa A. [11 ]
Graham, Gail E. [12 ]
Ranza, Emmanuelle [6 ]
Blundell, Tom L. [3 ]
Jackson, Andrew P. [1 ]
Stewart, Grant S. [4 ]
Bicknell, Louise S. [1 ]
机构
[1] Univ Edinburgh, Inst Genet & Mol Med, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland
[2] Univ Med Ctr Rotterdam, Erasmus MC, Dept Immunol, NL-3015 Rotterdam, Netherlands
[3] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England
[4] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England
[5] Univ Birmingham, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England
[6] Univ Hosp Geneva, Dept Med Genet, CH-1205 Geneva, Switzerland
[7] Gabriele DAnnunzio Univ Chieti Pescara, Dept Med Oral & Biotechnol Sci, I-66100 Chieti, Italy
[8] IRCCS Bambino Gesu Childrens Hosp, Endocrinol & Diabet Unit, I-00165 Rome, Italy
[9] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Dept Genet,INSERM,UMR 1163,Sorbonne Paris Cite,In, F-75015 Paris, France
[10] Guys & St Thomas NHS Fdn Trust, Guys Hosp, Dept Genet, London SE1 9RT, England
[11] Childrens Specialist Hosp, King Fahad Med City, Riyadh 11525, Saudi Arabia
[12] Childrens Hosp Eastern Ontario, Dept Genet, Ottawa, ON K1H 8L1, Canada
基金
英国惠康基金;
关键词
DNA-LIGASE-IV; DOUBLE-STRAND BREAKS; SEVERE COMBINED IMMUNODEFICIENCY; ORIGIN RECOGNITION COMPLEX; GROWTH FAILURE; DEVELOPMENTAL DISORDER; REPAIR; PROTEINS; GENE; PATIENT;
D O I
10.1016/j.ajhg.2015.01.013
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Non-homologous end joining (NHEJ) is a key cellular process ensuring genome integrity. Mutations in several components of the NHEJ pathway have been identified, often associated with severe combined immunodeficiency (SCID), consistent with the requirement for NHEJ during V(D)J recombination to ensure diversity of the adaptive immune system. In contrast, we have recently found that biallelic mutations in LIG4 are a common cause of microcephalic primordial dwarfism (MPD), a phenotype characterized by prenatal-onset extreme global growth failure. Here we provide definitive molecular genetic evidence supported by biochemical, cellular, and immunological data for mutations in XRCC4, encoding the obligate binding partner of LIG4, causing MPD. We report the identification of biallelic mutations in XRCC4 in five families. Biochemical and cellular studies demonstrate that these alterations substantially decrease XRCC4 protein levels leading to reduced cellular ligase IV activity. Consequently, NHEJ-dependent repair of ionizing-radiation-induced DNA double-strand breaks is compromised in XRCC4 cells. Similarly, immunoglobulin junctional diversification is impaired in cells. However, immunoglobulin levels are normal, and individuals lack overt signs of immunodeficiency. Additionally, in contrast to individuals with LIG4 mutations, pancytopenia leading to bone marrow failure has not been observed. Hence, alterations that alter different NHEJ proteins give rise to a phenotypic spectrum, from SCID to extreme growth failure, with deficiencies in certain key components of this repair pathway predominantly exhibiting growth deficits, reflecting differential developmental requirements for NHEJ proteins to support growth and immune maturation.
引用
收藏
页码:412 / 424
页数:13
相关论文
共 50 条
  • [11] XRCC4 codon 247*A and XRCC4 promoter-1394*T related genotypes but not XRCC4 intron 3 gene polymorphism are associated with higher susceptibility for endometriosis
    Hsieh, Yao-Yuan
    Bau, Da-Tian
    Chang, Chi-Chen
    Tsai, Chang-Hai
    Chen, Chih-Ping
    Tsai, Fuu-Jen
    MOLECULAR REPRODUCTION AND DEVELOPMENT, 2008, 75 (05) : 946 - 951
  • [12] Drug Design for XRCC4 in Silico
    Huang, Hung-Jin
    Tsai, Fuu-Jen
    Chung, Jing-Gung
    Tsai, Chang-Hai
    Hsu, Yuan-Man
    Ho, Tin-Yun
    Chang, Yea-Huey
    Bau, Da-Tian
    Tsai, Ming-Hsui
    Chen, Calvin Yu-Chian
    PROCEEDINGS OF THE 2009 2ND INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING AND INFORMATICS, VOLS 1-4, 2009, : 192 - +
  • [13] Lysine 271 but not lysine 210 of XRCC4 is required for the nuclear localization of XRCC4 and DNA ligase IV
    Fukuchi, Mikoto
    Wanotayan, Rujira
    Liu, Sicheng
    Imamichi, Shoji
    Sharma, Mukesh Kumar
    Matsumoto, Yoshihisa
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 461 (04) : 687 - 694
  • [14] Molecular genetic characterization of XRCC4 function
    Mizuta, R
    Cheng, HL
    Gao, YJ
    Alt, FW
    INTERNATIONAL IMMUNOLOGY, 1997, 9 (10) : 1607 - 1613
  • [15] Functional analysis of XRCC4 mutations in reported microcephaly and growth defect patients in terms of radiosensitivity
    Asa, Anie Day D. C.
    Wanotayan, Rujira
    Sharma, Mukesh Kumar
    Tsukada, Kaima
    Shimada, Mikio
    Matsumoto, Yoshihisa
    JOURNAL OF RADIATION RESEARCH, 2021, 62 (03) : 380 - 389
  • [16] The Role of XRCC4 in Carcinogenesis and Anticancer Drug Discovery
    Wu, Cheng-Nan
    Liang, Shiu-Yun
    Tsai, Chia-Wen
    Bau, Da-Tian
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2008, 3 (03) : 209 - 219
  • [17] Monoubiquitination of the nonhomologous end joining protein XRCC4
    Foster, RE
    Nnakwe, C
    Woo, L
    Frank, KM
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 341 (01) : 175 - 183
  • [18] Genotypic analysis of XRCC4 and susceptibility to cervical cancer
    Gupta, M. K.
    Kushwah, A. S.
    Singh, R.
    Banerjee, M.
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2020, 77 (01) : 7 - 12
  • [19] Prognostic significance of XRCC4 expression in hepatocellular carcinoma
    Lu, Jun
    Wang, Xing-Zhizi
    Zhang, Tian-Qi
    Huang, Xiao-Ying
    Yao, Jin-Guang
    Wang, Chao
    Wei, Zhong-Hong
    Ma, Yun
    Wu, Xue-Min
    Luo, Chun-Ying
    Xia, Qiang
    Long, Xi-Dai
    ONCOTARGET, 2017, 8 (50) : 87955 - 87970
  • [20] THE ROLE OF XRCC4 IN CARCINOGENESIS AND ANTICANCER DRUG DISCOVERY
    Bau, Da-Tian
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3209 - 3209